Madrigal Pharmaceuticals
MDGL
$205.25
Share price
-0.81%
Change (1 day)
-29.93%
Change (1 year)
Categories
EPS for Madrigal Pharmaceuticals (MDGL)
EPS in 2023 (TTM): -$18.65
According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$18.65. In 2022 the company made an earnings per share (EPS) of -$17.23 a decrease over its 2021 EPS that were of -$14.61.
EPS history for Madrigal Pharmaceuticals from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$18.65 | 8.24% |
| 2022 | -$17.23 | 17.93% |
| 2021 | -$14.61 | 11.61% |
| 2020 | -$13.09 | 140.18% |
| 2019 | -$5.45 | 146.61% |
| 2018 | -$2.21 | -12.99% |
| 2017 | -$2.54 | -91.03% |
| 2016 | -$28.31 | -14.83% |
| 2015 | -$33.24 | 6.71% |
| 2014 | -$31.15 | -29.92% |
| 2013 | -$44.45 | 19.81% |
| 2012 | -$37.10 | 6% |
| 2011 | -$35.00 | 7.53% |
| 2010 | -$32.55 | -139.74% |
| 2009 | $81.90 | -185.4% |
| 2008 | -$95.90 | -31.67% |
| 2007 | -$140.35 | 52.27% |
| 2006 | -$92.17 | -27.65% |
| 2005 | -$127.40 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -98.55% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -94.64% | 🇺🇸 USA |